Literature DB >> 26119398

A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia.

Ken Sano1, Shiroh Miura1, Toshiya Fujiwara2, Ryuta Fujioka2, Akiko Yorita3, Kazuhito Noda3, Hiroshi Kida3, Koichi Azuma3, Shinjiro Kaieda3, Ken Yamamoto4, Takayuki Taniwaki3, Yasuyuki Fukumaki2, Hiroki Shibata5.   

Abstract

Persistent elevation of serum creatine kinase (CK) without any symptoms has been called idiopathic hyper CK-emia (IHCK). We examined a four-generation Japanese pedigree of familial IHCK. The multipoint linkage analysis of the pedigree showed seven clear peaks of logarithm of odds (LOD) scores (>1.4). By the exome sequencing followed by multiple filtering processes, we identified one novel heterozygous nonsynonymous single nucleotide variant (SNV), c.7034G>C, p.S2345T in the ryanodine receptor 1 gene, RYR1 cosegregated with IHCK in the pedigree. Mutation Taster predicted this substitution as "disease causing" (p=0.999). The PolyPhen-2 and PANTHER subPSEC scores for the substitution are 0.911 (possibly damaging) and -3.56 (probably damaging), respectively. We confirmed the absence of the SNV in 511 healthy Japanese individuals excluding the possibility of a normal variant with a very low frequency. Immunohistochemistry and Western blotting of biopsy samples consistently showed the expression level of RYR1 reduced in the patient. In real-time RT-PCR, the mRNA expression level of RYR1 was also significantly reduced in the patient (p=0.009). These results suggest that the novel nonsynonymous SNV contribute to the vulnerability of the RYR1 protein through the dominant negative effect. We conclude that the SNV in the RYR1 gene is one of the responsible genes of IHCK.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autosomal dominant; Creatine kinase; Exome sequencing; Hyper CK-emia; Malignant hyperthermia; Ryanodine receptor

Mesh:

Substances:

Year:  2015        PMID: 26119398     DOI: 10.1016/j.jns.2015.06.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  JSA guideline for the management of malignant hyperthermia crisis 2016.

Authors: 
Journal:  J Anesth       Date:  2017-02-28       Impact factor: 2.078

2.  Linkage analysis and whole exome sequencing reveals AHNAK2 as a novel genetic cause for autosomal recessive CMT in a Malaysian family.

Authors:  Shelisa Tey; Nortina Shahrizaila; Alexander P Drew; Sarimah Samulong; Khean-Jin Goh; Esra Battaloglu; Derek Atkinson; Yesim Parman; Albena Jordanova; Ki Wha Chung; Byung-Ok Choi; Yi-Chung Li; Michaela Auer-Grumbach; Garth A Nicholson; Marina L Kennerson; Azlina Ahmad-Annuar
Journal:  Neurogenetics       Date:  2019-04-22       Impact factor: 2.660

3.  A novel de novo KCNB1 variant altering channel characteristics in a patient with periventricular heterotopia, abnormal corpus callosum, and mild seizure outcome.

Authors:  Takuya Hiraide; Tenpei Akita; Kenji Uematsu; Sachiko Miyamoto; Mitsuko Nakashima; Masayuki Sasaki; Atsuo Fukuda; Mitsuhiro Kato; Hirotomo Saitsu
Journal:  J Hum Genet       Date:  2022-10-18       Impact factor: 3.755

4.  A novel 1-bp deletion variant in DAG1 in Japanese familial asymptomatic hyper-CK-emia.

Authors:  Luoming Fan; Shiroh Miura; Tomofumi Shimojo; Hirotoshi Sugino; Ryuta Fujioka; Hiroki Shibata
Journal:  Hum Genome Var       Date:  2022-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.